Advertisement

Chemo Fog

Cancer Chemotherapy-Related Cognitive Impairment

  • Robert B. Raffa
  • Ronald J. Tallarida

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 678)

Table of contents

  1. Front Matter
    Pages i-xxi
  2. Robert B. Raffa
    Pages 1-10
  3. Robert B. Raffa, Kathleen J. Martin
    Pages 11-12
  4. Jamie S. Myers
    Pages 13-18
  5. Rachel Clark-Vetri
    Pages 19-20
  6. Albert I. Wertheimer
    Pages 33-36
  7. Robert B. Raffa
    Pages 113-118
  8. Ronald J. Tallarida
    Pages 133-137
  9. Ellen A. Walker
    Pages 138-146
  10. Christopher D. Aluise, Rukhsana Sultana, Jitbangjong Tangpong, Mary Vore, Daret St. Clair, Jeffrey A. Moscow et al.
    Pages 147-156
  11. Peter M. Wigmore, Sarah Mustafa, Maha El-Beltagy, Laura Lyons, Jariya Umka, Geoff Bennett
    Pages 157-164
  12. Robert B. Raffa, Ronald J. Tallarida
    Pages 165-167
  13. Back Matter
    Pages 169-216

About this book

Introduction

Cancer patients have benefitted greatly from recent advances in the drugs, dose regimens, and combinations used to treat their primary tumor and for the treatment or prevention of spread of their disease. Due to the advances in chemotherapy and other aspects of prevention, early detection, and treatment modalities, an increasing percentage of patients are surviving the disease. For some types of cancer, the majority of patients live decades beyond their diagnosis. For this they are forever thankful and appreciative of the drugs that helped lead to this increased survival rate. But no drug is devoid of adverse effects. This also applies to chemotherapeutic agents. The acute cytotoxic effects of these agents are well known––indeed are often required for their therapeutic benefit. The chronic adverse effects are varied and in some cases less well known. With the increase in survival rates, there has emerged a new awareness of these chronic adverse effects.

Keywords

Cancer Chemo Fog Raffa Tallarida imaging

Editors and affiliations

  • Robert B. Raffa
    • 1
  • Ronald J. Tallarida
    • 2
  1. 1.Department of Pharmaceutical SciencesTemple University School of PharmacyPhiladelphiaUSA
  2. 2.Department of PharmacologyTemple University School of MedicinePhhiladelphiaUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4419-6306-2
  • Copyright Information Landes Bioscience and Springer Science+Business Media, LLC 2010
  • Publisher Name Springer, New York, NY
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-1-4419-6305-5
  • Online ISBN 978-1-4419-6306-2
  • Series Print ISSN 0065-2598
  • Series Online ISSN 2214-8019
  • Buy this book on publisher's site
Industry Sectors
Pharma
Biotechnology
Consumer Packaged Goods